These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27759575)

  • 1. Changes in Urinary Biomarkers Over 10 Years Is Associated With Viral Suppression in a Prospective Cohort of Women Living With HIV.
    Baxi SM; Scherzer R; Jotwani V; Estrella MM; Abraham AG; Parikh CR; Bennett MR; Cohen MH; Nowicki MJ; Gustafson DR; Sharma A; Young MA; Shlipak MG;
    J Acquir Immune Defic Syndr; 2017 Apr; 74(5):e138-e145. PubMed ID: 27759575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does HIV infection promote early kidney injury in women?
    Jotwani V; Scherzer R; Abraham A; Estrella MM; Bennett M; Devarajan P; Anastos K; Cohen MH; Nowicki M; Sharma A; Young M; Tien PC; Grunfeld C; Parikh CR; Shlipak MG
    Antivir Ther; 2014; 19(1):79-87. PubMed ID: 23970313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of urine biomarker-derived clusters to predict the risk of chronic kidney disease and all-cause mortality in HIV-infected women.
    Scherzer R; Lin H; Abraham A; Thiessen-Philbrook H; Parikh CR; Bennett M; Cohen MH; Nowicki M; Gustafson DR; Sharma A; Young M; Tien P; Jotwani V; Shlipak MG
    Nephrol Dial Transplant; 2016 Sep; 31(9):1478-85. PubMed ID: 26754833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of CKD risk factors and longitudinal changes in urine biomarkers of kidney tubules among women living with HIV.
    Muiru AN; Scherzer R; Ascher SB; Jotwani V; Grunfeld C; Shigenaga J; Spaulding KA; Ng DK; Gustafson D; Spence AB; Sharma A; Cohen MH; Parikh CR; Ix JH; Estrella MM; Shlipak MG
    BMC Nephrol; 2021 Aug; 22(1):296. PubMed ID: 34461840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney disease risk factors associate with urine biomarkers concentrations in HIV-positive persons; a cross-sectional study.
    Muiru AN; Shlipak MG; Scherzer R; Zhang WR; Ascher SB; Jotwani V; Grunfeld C; Parikh CR; Ng D; Palella FJ; Ho K; Kassaye S; Sharma A; Cohen M; Wang R; Qi Q; Estrella MM
    BMC Nephrol; 2019 Jan; 20(1):4. PubMed ID: 30606136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of Urine Biomarkers with Kidney Function Decline in HIV-Infected and Uninfected Men.
    Ascher SB; Scherzer R; Estrella MM; Shlipak MG; Ng DK; Palella FJ; Witt MD; Ho K; Bennett MR; Parikh CR; Ix JH; Jotwani V
    Am J Nephrol; 2019; 50(5):401-410. PubMed ID: 31553981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary markers of kidney injury and kidney function decline in HIV-infected women.
    Shlipak MG; Scherzer R; Abraham A; Tien PC; Grunfeld C; Peralta CA; Devarajan P; Bennett M; Butch AW; Anastos K; Cohen MH; Nowicki M; Sharma A; Young MA; Sarnak MJ; Parikh CR
    J Acquir Immune Defic Syndr; 2012 Dec; 61(5):565-73. PubMed ID: 23023103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary kidney injury molecule 1 (KIM-1) and interleukin 18 (IL-18) as risk markers for heart failure in older adults: the Health, Aging, and Body Composition (Health ABC) Study.
    Driver TH; Katz R; Ix JH; Magnani JW; Peralta CA; Parikh CR; Fried L; Newman AB; Kritchevsky SB; Sarnak MJ; Shlipak MG;
    Am J Kidney Dis; 2014 Jul; 64(1):49-56. PubMed ID: 24656453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of urine α1-microglobulin with kidney function decline and mortality in HIV-infected women.
    Jotwani V; Scherzer R; Abraham A; Estrella MM; Bennett M; Cohen MH; Nowicki M; Sharma A; Young M; Tien PC; Ix JH; Sarnak MJ; Parikh CR; Shlipak MG
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):63-73. PubMed ID: 25370597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of CD4+ blood cell count and HIV viral load on treatment response with direct acting antivirals in HIV and HCV coinfected patients: insights from the German Hepatitis C-Registry.
    Bischoff J; Mauss S; Cordes C; Lutz T; Scholten S; Cornberg M; Manns MP; Baumgarten A; Rockstroh JK
    HIV Clin Trials; 2018 Dec; 19(6):225-234. PubMed ID: 30890063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of proteinuria and renal failure among women with HIV infection.
    Szczech LA; Gange SJ; van der Horst C; Bartlett JA; Young M; Cohen MH; Anastos K; Klassen PS; Svetkey LP
    Kidney Int; 2002 Jan; 61(1):195-202. PubMed ID: 11786101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anemia risk factors among people living with HIV across the United States in the current treatment era: a clinical cohort study.
    Harding BN; Whitney BM; Nance RM; Ruderman SA; Crane HM; Burkholder G; Moore RD; Mathews WC; Eron JJ; Hunt PW; Volberding P; Rodriguez B; Mayer KH; Saag MS; Kitahata MM; Heckbert SR; Delaney JAC
    BMC Infect Dis; 2020 Mar; 20(1):238. PubMed ID: 32197585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Kidney Function and Early Kidney Injury With Incident Hypertension in HIV-Infected Women.
    Ascher SB; Scherzer R; Peralta CA; Tien PC; Grunfeld C; Estrella MM; Abraham A; Gustafson DR; Nowicki M; Sharma A; Cohen MH; Butch AW; Young MA; Bennett MR; Shlipak MG
    Hypertension; 2017 Feb; 69(2):304-313. PubMed ID: 27993956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Hepatitis C Virus Infection With CD4/CD8 Ratio in HIV-Positive Women.
    Kuniholm MH; OʼBrien TR; Prokunina-Olsson L; Augenbraun M; Plankey M; Karim R; Sarkar M; French AL; Pierce C; Strickler HD; Anastos K
    J Acquir Immune Defic Syndr; 2016 Jun; 72(2):162-70. PubMed ID: 27183178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary beta-2 microglobulin and alpha-1 microglobulin are useful screening markers for tenofovir-induced kidney tubulopathy in patients with HIV-1 infection: a diagnostic accuracy study.
    Nishijima T; Shimbo T; Komatsu H; Takano M; Tanuma J; Tsukada K; Teruya K; Gatanaga H; Kikuchi Y; Oka S
    J Infect Chemother; 2013 Oct; 19(5):850-7. PubMed ID: 23467792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study.
    Zhang WR; Craven TE; Malhotra R; Cheung AK; Chonchol M; Drawz P; Sarnak MJ; Parikh CR; Shlipak MG; Ix JH;
    Ann Intern Med; 2018 Nov; 169(9):610-618. PubMed ID: 30357395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBV or HCV Coinfection in HIV-1-Infected Pregnant Women in France: Prevalence and Pregnancy Outcomes.
    Benhammou V; Tubiana R; Matheron S; Sellier P; Mandelbrot L; Chenadec JL; Marel E; Khoshnood B; Warszawski J;
    J Acquir Immune Defic Syndr; 2018 Apr; 77(5):439-450. PubMed ID: 29287028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenofovir disoproxil fumarate initiation and changes in urinary biomarker concentrations among HIV-infected men and women.
    Zhang WR; Scherzer R; Estrella MM; Ascher SB; Muiru A; Jotwani V; Grunfeld C; Parikh CR; Gustafson D; Kassaye S; Sharma A; Cohen M; Tien PC; Ng DK; Palella FJ; Witt MD; Ho K; Shlipak MG
    AIDS; 2019 Mar; 33(4):723-733. PubMed ID: 30830887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical efficacy of pegylated interferon in patients co-infected with HIV and HCV who failed standard interferon therapy].
    Ke YC; Li LH; Hu FY; He Y; Lan Y; Chen XJ; Tang XP; Cai WP
    Zhonghua Gan Zang Bing Za Zhi; 2016 Mar; 24(3):181-5. PubMed ID: 27095760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediation analysis of chronic kidney disease risk factors using kidney biomarkers in women living with HIV.
    Edrosolan KA; Shlipak MG; Scherzer R; Estrella MM; Gustafson D; Karim R; Fisher M; Cohen M; Kassaye S; Dumond J; Abraham A; McCulloch CE; Ascher SB
    AIDS; 2024 May; 38(6):813-824. PubMed ID: 38224361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.